welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
study id #: NCT02198092
condition: Familial Adenomatous Polyposis, Map Syndrome, Lynch Syndrome, HNPCC, Colorectal Cancer
This is an observational, case-control study evaluating the quantitative level of Septin9 in plasma pre- and post-colectomy in hereditary colorectal cancer (CRC) syndrome patients (Familial Adenomatous Polyposis (FAP), Lynch syndrome (also known as HNPCC), and Multiple Adenomatous Polyposis (MAP, also known as MYK/MYH) cases) and genetically related FAP-family members as controls and references.
intervention: Other: Epi proColon Testing
start date: July 2014
estimated completion: August 2019
last updated: August 28, 2019
size / enrollment: 24
study design: Observational Model: Case Control, Time Perspective: Prospective
- Septin9 Plasma Levels [ Time Frame: Up to 2 years ]
The primary objective of the study is the observational analysis of quantitative Septin9 plasma levels over time in hereditary CRC syndrome patients pre- and post-colectomy.
- Septin9 Plasma Levels Versus Polyps [ Time Frame: Up to 2 years ]
Correlation of quantitative Septin9 plasma levels with the approx. number of polyps
- Pre- and Post-Colectomy Colonic Epithelial Cell Numbers [ Time Frame: Up to 2 years ]
Correlation of circulating colonic epithelial cell number pre- and post-colectomy
- Septin9 Levels Versus Circulating Colonic Epithelial Cell Numbers [ Time Frame: Up to 2 years ]
Correlation of circulating colonic epithelial cell number with Septin9 levels
• Informed consent provided
• Age > or = to 18 years of age
• Patient group FAP
- Clinical diagnosis of familial adenomatous polyposis
• Patient group Lynch syndrome Clinical diagnosis of Lynch syndrome
• Patient group MAP
- Clinical diagnosis of MYH-associated polyposis and presence of more than 20 colon polyps
• Control group (FAP)
- Genetically related family member of patient
• Patients: Able and willing to attend routine follow-up as advised
• Controls, i.e. relatives of patients: Willingness to give blood at each routine follow-up as advised for the diseased relative
• Known infection with Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), or Hepatitis C Virus (HCV)
• Current diagnosis of colorectal cancer
expertly curated content related to this topic
- Lynch Syndrome and MYH-Associated Polyposis: Review and Testing StrategyIndividuals with Lynch syndrome have an ...
- Studies of the Foregut in Patients with Familial Adenomatous Polyposis (FAP): The Clinical Problem, Management, and ...Thirty-eight published papers, co-author...
- Colorectal Carcinomas, A Consideration on MutYH-Associated PolyposisColorectal cancer (CRC) is the second mo...
- MUTYH-Associated Polyposis – Variability of the Clinical Phenotype in Patients with Biallelic and Monoallelic ...To further characterize 215 APC mutation...
- Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis PatientsThe purpose of this registry is to colle...
- An AT-Rich Region in the APC Gene may cause Misinterpretation of Familial Adenomatous Polyposis Molecular ScreeningFamilial adenomatous polyposis (FAP) is ...
- The Wnt/Beta-Catenin Pathway and Familial Adenomatous Polyposis Part 2https://www.youtube.com/watch?v=p2mWc0IG...